Recent News

• 06.12.2025 - New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
• 06.11.2025 - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
• 05.19.2025 - Teleflex Publishes 2024 Global Impact Report
• 05.15.2025 - Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
• 05.13.2025 - New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
• 05.12.2025 - Teleflex Announces Quarterly Dividend
• 05.01.2025 - Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

Recent Filings

• 05.29.2025 - SD Specialized disclosure report
• 05.15.2025 - 8-K Current report
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities